NOCIL News and Updates

Name: Latest research reports of NOCIL Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: NOCIL Ltd.
Rating: 1
Author: Axis Direct

Keep track of all breaking news on NOCIL from all sources in a single place.

NOCIL Ltd.

04 Nov 2025

144.10

1.52%

Result Update:NOCIL

Sell: NOCIL Ltd.

Axis Direct

We maintain our SELL Rating on the Stock.

NOCIL Ltd. has an average target of 168.33 from 3 brokers.

NOCIL Ltd.

03 Nov 2025

144.10

1.52%

NOCIL Ltd. Results Earnings Call for Q2FY26

Conference Call with NOCIL Ltd. Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.

audio

NOCIL Ltd.

03 Nov 2025

144.10

1.52%

Challenging operating environment hurts 2Q performance

Neutral: NOCIL Ltd.

Target

Motilal Oswal

NOCIL’s 2QFY26 was weak, with revenue declining 12% YoY to INR3.2b. EBITDA also declined 44% due to continued pricing pressure in the domestic market.

NOCIL Ltd. is trading above its 30 day SMA of 140.8

NOCIL Ltd.

03 Nov 2025

144.10

1.52%

Strong revenue traction; opex elevated

ipo note: NOCIL Ltd.

Motilal Oswal

CDSL’s operating revenue declined 1% YoY but grew 23% QoQ to INR3.2b (7% beat) in 2QFY26. The sequential growth was propelled by a 195% growth in IPO & corporate action charges and 28% growth in online data charges.

NOCIL has lost -35.46% in the last 1 Year

NOCIL Ltd.

03 Nov 2025

144.10

1.52%

NOCIL (NOCIL IN) Q2FY26 Result Update Headwinds continue...

Hold: NOCIL Ltd.

Target

Prabhudas Lilladhar

Number of FII/FPI investors decreased from 124 to 112 in Dec 2025 qtr

NOCIL Ltd.

11 Aug 2025

144.10

1.52%

Result Update:NOCIL

Sell: NOCIL Ltd.

Recommendation Target

Axis Direct

We downgrade our rating form HOLD to SELL on the stock as the hopes of a turnaround now seem distant.

NOCIL Ltd. is trading below its 50 day SMA of 149.0

NOCIL Ltd.

09 Aug 2025

144.10

1.52%

Muted outlook with limited near-term growth prospects

Neutral: NOCIL Ltd.

Target

Motilal Oswal

1QFY26 was a muted quarter for NOCIL, with revenue declining 10% YoY to INR3.3b, while EBITDA margin contracted 190bp YoY to 8.8% due to continued pricing pressure in the domestic market.

NOCIL has lost -35.46% in the last 1 Year

NOCIL Ltd.

08 Aug 2025, 12:00AM

144.10

1.52%

NOCIL (NOCIL IN) Q1FY26 Result Update All eyes...

Hold: NOCIL Ltd.

Recommendation Target

Prabhudas Lilladhar

Overall capacity utilization at ~65%; utilization varies across products company's product portfolio, we upgrade the stock to HOLD' with a revised target price of Rs182, valuing it at 26x FY27E EPS. NOCIL reported revenue of Rs3.4bn (PLe: Rs3.55bn, Consensus: Rs3.48bn), marking a decline of 9.7% YoY and 1% QoQ. The topline was impacted by a 7% YoY drop in volumes and lower realization. Based on our estimates, the average realization stood at Rs250/kg,...

NOCIL Ltd. is trading below its 50 day SMA of 149.0

NOCIL Ltd.

17 May 2025

144.10

1.52%

Cautious outlook with muted near-term growth

Neutral: NOCIL Ltd.

Target

Motilal Oswal

NOCIL's EBITDA/kg missed our estimate and stood at INR25.1 in 4QFY25, down 19% YoY. Sales volume declined 4% YoY to 13.4tmt. Realization was flat YoY at INR254.2/kg (INR255.1/kg in 4QFY24) amid persistent pricing pressure from Chinese, Korean and EU players.

NOCIL Ltd. is trading above its 30 day SMA of 140.8

NOCIL Ltd.

16 May 2025

144.10

1.52%

NOCIL (NOCIL IN) Q4FY25 Result Update Near-term headwinds...

Sell: NOCIL Ltd.

Target

Prabhudas Lilladhar

Overall capacity utilization at ~65%; utilization varies across products reflecting 5% YoY decline but 7% QoQ increase. The topline was impacted by ~5% drop in sales volume YoY and marginal decline in the specialty product mix. Based on our estimates, average realizations stood flat YoY at Rs255/kg. Sales volume declined 5% YoY but grew 4% sequentially. However, EBITDA /kg fell 20% YoY, primarily due to higher operating leverage, resulting in a 240bps...

NOCIL Ltd. is trading above its 30 day SMA of 140.8

Is NOCIL Ltd. worth buying?

460 Votes:

Buy 80.22%

Sell 11.74%

Hold 8.04%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf